Here, we generated a COVID-19 vaccine based on the proprietary secreted heat shock protein, gp96-Ig vaccine strategy, that induces antigen-specific CD8+ T lymphocytes in epithelial tissues, including lungs. Here, CD8A is linked to COVID-19.